David Sudolsky has led Anellotech since its founding in 2008. He has secured over $100 million in strategic partner funding as Anellotech completed development of the Bio-TCat Process (non-food biomass to BTX) and is now pioneering the Plas-TCat Process (chemical recycling of mixed plastics to BTX and light olefins). Prior to joining Anellotech, David was a business officer or CEO of five biotechnology, specialty pharmaceutical and bioprocessing start-ups, one of which (Dura Pharmaceuticals) was sold for $1.8 billion. He has hands-on chemical engineering experience in process design and refinery plant startups with Union Carbide, and in strategy management consulting at Booz, Allen & Hamilton. David attended Columbia University and earned an MBA in Marketing and Finance from the University’s Business School and a B.S. in Chemical Engineering.